1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Counter UAS Technologies is sponsored by Innovate UK. Counter UAS Technologies. Funding opportunity from Innovate UK.
Funding: £5 million. Apply via the UKRI portal.
Get alerted about grants like this
Save a search for “Innovate UK” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Counter UAS Technologies – UKRI Funding opportunity: Counter UAS Technologies 5 May 2026 9:30am UK time 3 June 2026 11:00am UK time See the full opportunity details on the Innovation Funding Service . UK registered organisations can apply for a share of up to £5 million to develop counter Uncrewed Aerial Systems (UAS) dual use technologies that can be applied to both civil and military settings. This funding is from Innovate UK.
This competition is open to collaborations only. To lead a collaborative project your organisation must be either a UK registered business of any size or a UK public sector organisation. The consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding on this application.
This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .
Based on current listing details, eligibility includes: UK-based researchers, institutions, and organisations. International collaborators may be eligible depending on the specific scheme. See the opportunity page for detailed eligibility criteria. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Funding amounts vary based on project scope and sponsor guidance. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is June 3, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Innovate UK's Sovereign AI Proof of Concept programme funds proof of concept demonstrators of AI technologies with state-of-the-art performance across five strategic themes: fundamental AI research, materials discovery, biosciences and health, defense and national security, and AI-aided chip/hardware design. Individual project grants range from £50,000 to £120,000 (approximately USD $63,500-$152,400) from a total allocation of at least £1.6 million. Projects must be 1-3 months in duration, starting by January 2026 and completing by March 2026. The programme supports feasibility studies and industrial research, with funding covering up to 70% of costs for micro/small businesses, 60% for medium, and 50% for large organizations. Literature review studies and projects unable to scale are excluded.
The Biomedical Catalyst – Industry-led R&D (Small Projects) is a grant from Innovate UK (part of UKRI) that funds the development of innovative solutions to health and healthcare challenges. The programme supports small-scale industry-led R&D projects and is open to both single applicants and collaborative teams. Eligible applicants are UK-registered micro, small, and medium-sized enterprises (SMEs). A total of up to £25 million is available across the competition, with applications closing on 10 December 2025. To lead or work alone on a project, organisations must hold UK SME status and register through the Innovation Funding Service.
The OCRP Outcomes Consortium Development Award supports a multi-institutional research effort conducted by leading ovarian cancer researchers and consumer advocates that specifically focuses on identifying and understanding predictors of disease outcomes in ovarian cancer patients. This effort will be executed through a two-stage approach using two separate award mechanisms: this FY12 Outcomes Consortium Development Award, which will enable the consortium to lay the groundwork for the research project, including proof of concept, and the FY14 Outcomes Consortium Award, which will support the execution of the full research project. Funding Opportunity Number: W81XWH-12-OCRP-OCDA. Assistance Listing: 12.420. Funding Instrument: CA,G. Category: ST. Award Amount: $1.3M total program funding.
SBIR/STTR Programs is sponsored by Defense Health Agency (DHA). The DHA SBIR and STTR programs support U.S. small businesses in developing high-risk, high-impact medical materiel technologies with potential for wider commercialization, including those that could leverage AI for warfighter health and survival. This program seeks proposals that demonstrate both technical innovation and real clinical relevance in areas such as trauma care, battlefield triage, far-forward telemedicine, and digital health systems with AI-enabled triage.
Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Program is sponsored by Defense Health Agency (DHA). The DHA SBIR program provides funding and support for small businesses to develop innovative healthcare technologies and solutions that benefit the military. It focuses on biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization. Topics are aligned with real-world needs such as trauma care, telemedicine, infectious disease diagnostics, and wearable monitoring tools.